Hemex is a venture capital fund based in Basel, focusing on Series B stage Health Tech companies with investments ranging from $250k to $5M. They have invested in firms such as Hemotune. Beyond funding, Hemex offers clinical services, aiding biotech and medtech companies through clinical development. With offices in Germany, Benelux, and the U.S., they support small and medium enterprises on international clinical projects. Their services include clinical operations, quality management, regulatory guidance, and fundraising, providing clear communication and local accessibility.
